Fas88 Design Improves CAR Vdelta2 Persistence in Models

Company Leong Lab (academic) Event Type Peer-reviewed publication (Nature Communications) Modality Gamma-delta CAR T with cytokine-armoring (Fas–MyD88 fusion) Asset Fas88 CAR-Vδ2 T cells Target CD19; CD5; PSCA (models); Fas signaling Disease Area Leukemia; T-ALL; pancreatic cancer (xenograft models) Summary A Nature Communications peer-reviewed paper appeared…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *